Building Biotech – Challenges and Opportunities In and Out of Canada

September 28, 2017 6:00 pm - 9:30 pm Coast Coal Harbour Hotel (1180 W Hastings St, Vancouver)


The Discovery Foundation and the Student Biotechnology Network are delighted to kick off the 2017-2018 season with our annual Building Biotech Event. This year, with Building Biotech: Challenges and Opportunities In and Out of Canada, we hope that the stories that are shared and ideas exchanged inspire you to continue to reach for the stars.

If the success of previous events is anything to go by, this evening is an excellent opportunity to re-connect with other enthusiastic students and industry professionals, while gaining insight and perspectives on the local life sciences industry over a delicious three course dinner.

Time Program Speaker
6:00-6:45 Registration & Networking Reception
6:45-8:15 Opening Remarks & Dinner Leo Chen
President, Student Biotechnology Network
8:15-9:15 Panel Discussion Catalina Lopez-Correa
Chief Scientific Officer and Vice President, Genome BCCarl Hansen
CEO & President, Co-Founder, AbcelleraGordon Ng

Jerel Davis
Managing Director – Versant Ventures

Natalie Dakers
President & CEO – Accel-RX Health Sciences Accelerator

9:15-10:00 Closing Reception

Jerel Davis


Gordon Ng


Carl Hansen (CEO & President, Co-Founder, Abcellera)

Dr. Carl L. Hansen, Ph.D. serves as the President and Chief Executive Officer at AbCellera Biologics Inc. Dr. Hansen has a proven track record in the development and transfer of microfluidic technologies. He serves as a Director of AbCellera Biologics Inc. He served as a Director of Precision Nanosystems, Inc. He has served as Member of Advisory Board of Fluidigm Corporation since May 2008. Dr. Hansen, Ph.D. is an Assistant Professor in the Department of Physics and Astronomy at the University of British Columbia. He is a co-inventor on over 30 US and international patent filings in this field and his work has directly lead to the commercialization of two microfluidic products by Fluidigm Corp. (San Francisco). Dr. Hansen received a Ph.D. and M.S. in Applied Physics from the California Institute of Technology and a B.S. in Engineering Physics/Electrical Engineering/Honors Math from the University of British Columbia.

Catalina Lopez-Correa (Chief Scientific Officer and Vice President, Genome BC)


Dr. Catalina Lopez-Correa joined Genome BC in January 2016. With over 18 years of international experience in both the academic and private sectors, Dr. Lopez-Correa brings her deep understanding of genomics to the Genome BC leadership team. Dr. Lopez-Correa holds an MD from UPB University in Colombia, a Masters in Genetics from Paris VII/Pasteur Institute and a PhD in Medical Biosciences-Genetics from KULeuven in Belgium. Most recently she was the Vice-President and CSO, Scientific Affairs, at Genome Quebec where she was instrumental in developing competitive teams for national and provincial research projects, and raising the profile of Genome Quebec on the global stage.

Since 2002, Dr. Lopez-Correa has served as evaluator for large multinational projects funded by the European Commission, the IMI (Innovative Medicines Initiatives) and the NIH and has been recognized by several awards nationally and internationally. As part of her commitment to international development, Dr. Lopez-Correa funded the not for profit organization ODNS (Organisation pour le Développement avec des Nouvelles Solidarités) in 2012 and has been involved in several initiatives aimed at demonstrating the impact of genomics in developing countries.


The SBN Building Biotech event is a business formal event at the beautiful Coast Coal Harbour Hotel. Students will have the opportunity to learn about the current state of the life sciences industry in BC and gain insights as to which areas within life sciences are growing and declining, as well as learn about what economic factors influence the local industry. Our expert panel of speakers will also give their outlook on the future of life sciences in BC.

The following organizations were present at last year’s event:

Augurex Life Sciences Corp.
BCIT Biotechnology
Cannevert Therapeutics
CAPRA International Marketing
Contextual Genomics
Cross Pacific Capital Partners
Genome Sciences Centre, BCCA
Health Canada
Paladin Labs Inc.
Precision NanoSystems Inc.
Simon Fraser University
STEMCELL Technologies Inc.
Tait Labs
University of British Columbia
ZymeWorks Inc.

Share This Article :
  • Platinum

  • Gold

  • Silver

  • Friends of SBN